HUMA (HUMA) Stock Price & Analysis
HUMA (HUMA) rose 0.86% to USD 0.6 as of September 9, 2026 at 13:35 UTC, according to Nexqual real-time market data.
HUMA last closed at USD 0.6; the session ranged USD 0.59–0.6 on volume of 230,231 shares. Market capitalization is —, with a 52-week range of USD 0.53–2.55 (NMS). Source: Nexqual, September 9, 2026 at 13:35 UTC.
Key Statistics (as of September 9, 2026 at 13:35 UTC)
| Price | USD 0.6 |
|---|---|
| Change | ▲ 0.86% (up) |
| Previous Close | USD 0.6 |
| Open | USD 0.6 |
| Day Range | USD 0.59 – 0.6 |
| 52-Week Range | USD 0.53 – 2.55 |
| Volume | 230,231 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (HUMA)
Nexqual's technical model rates HUMA "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 9, 2026 at 13:35 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.5 (neutral) |
| vs SMA50 | Below (USD 0.67) |
| MACD | -0.03 (negative) |
From HUMA's Latest SEC 10-K Filing (filed 2026-03-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | USD 3.46 | ▼ 10.13% |
| ABSI | Absci Corporation | USD 8.89 | ▲ 0.79% |
| QSI | Quantum-Si Incorporated | USD 0.77 | ▲ 0.26% |
| TNYA | Tenaya Therapeutics, Inc. | USD 0.68 | ▼ 0.2% |
| IBRX | ImmunityBio, Inc. | USD 8.13 | ▲ 0.62% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 13:35 UTC. This page is informational and not investment advice.